Bio-Rad Laboratories (BUWA) Income Statement
Bio-Rad Laboratories Income Statement
Last quarter (Q2 2026), Bio-Rad Laboratories's total revenue was $651.00M, a decrease of 0.09% from the same quarter last year. In Q2, Bio-Rad Laboratories's net income was $371.40M. See Bio-Rad Laboratories’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 2.58B | $ 2.57B | $ 2.67B | $ 2.80B | $ 2.92B | |
| $ 1.34B | $ 1.38B | $ 1.43B | $ 1.57B | $ 1.64B | |
| $ 1.08B | $ 1.11B | $ 1.09B | $ 1.08B | $ 1.14B | |
| Depreciation and Amortization | $ 165.40M | $ 151.60M | $ 145.90M | $ 137.30M | $ 137.60M |
| $ 1.21B | $ -2.14B | $ -654.80M | $ -4.53B | $ 5.59B | |
| $ 270.50M | $ 269.00M | $ 337.80M | $ 482.62M | $ 500.34M | |
| $ 725.00M | $ -2.61B | $ -1.19B | $ -5.19B | $ 4.95B | |
| $ 995.50M | $ -2.34B | $ -850.10M | $ -4.70B | $ 5.45B | |
| $ 759.90M | $ -1.84B | $ -637.32M | $ -3.63B | $ 4.25B | |
| Per Share Metrics | |||||
| Basic EPS | $ 27.87 | $ -65.36 | $ -21.82 | $ -121.79 | $ 142.61 |
| Diluted EPS | $ 27.87 | $ -65.36 | $ -21.82 | $ -121.79 | $ 140.83 |
| Weighted Average Shares Outstanding | 27.26M | 28.21M | 29.21M | 29.79M | 29.83M |
| Weighted Average Shares Outstanding (Diluted) | 27.28M | 28.21M | 29.21M | 29.79M | 30.21M |
Currency in USD